Prognostic value and clinicopathologic c
โ
Alan G. Casson; Sheryl McCuaig; Ian Craig; Adel Ayed; Richard Inculet; Nancy Ker
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 708 KB
The aim of this prospective study was to determine whether use of a combination of biomarkers, p53 and nuclear DNA content, led to improved prognosis and clinicopathologic correlation in human non-small cell lung cancer. Nineteen patients undergoing curative resection of p imary non-small cell lung